Sign in
4

Changes in Ownership

RELMADA THERAPEUTICS, INC. Filed Acc 0001213900-21-005451

CFO sold 3,000 shares at an average $31.93 ($95,778)

  • CFO acquired 3,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Shenouda Maged · CFO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2021-01-27 Exercise or conversion : show line 1 in the form +3,000 $3.24 $9,720 5,228 D
2021-01-27 Sale : show line 2 in the form −1,800 $31.59 $56,862 3,428 D
2021-01-27 Sale : show line 3 in the form −1,200 $32.43 $38,916 2,228 D
Open-market sales · 3,000 sh · avg $31.93 · $95,778

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-01-27 Exercise or conversion : show line 4 in the form Options to purchase common stock −3,000 99,250 D
Loading xslF345X03/ownership.xml…